Genus (FRA:GBE) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Genus Days Payable?

Genus's average Accounts Payable for the six months ended in Dec. 2023 was €40.5 Mil. Genus's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.0 Mil.

The historical rank and industry rank for Genus's Days Payable or its related term are showing as below:

FRA:GBE' s Days Payable Range Over the Past 10 Years
Min: 21.54 Med: 26.23 Max: 62.69
Current: 28.69

During the past 13 years, Genus's highest Days Payable was 62.69. The lowest was 21.54. And the median was 26.23.

FRA:GBE's Days Payable is ranked worse than
83.75% of 714 companies
in the Biotechnology industry
Industry Median: 148.12 vs FRA:GBE: 28.69

Genus's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Genus Days Payable Historical Data

The historical data trend for Genus's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Days Payable Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

62.89

59.25

21.12

28.80

28.68

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genus's Days Payable

For the Biotechnology subindustry, Genus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Days Payable distribution charts can be found below:

* The bar in red indicates where Genus's Days Payable falls into.

Genus Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genus's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (41.941	+	40.556)	/	2 )	/	524.898	*	365
=	41.2485					/	524.898	*	365
=	28.68

Genus's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (40.556	+	40.511)	/	2 )	/	0	*	365 / 2
=	40.5335					/	0	*	365 / 2
=	N/A

Genus Days Payable Related Terms

Thank you for viewing the detailed overview of Genus's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (FRA:GBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GNS:UK

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (FRA:GBE) Headlines

No Headlines